Current opportunities of device-based treatment of arterial hypertension


DOI: https://dx.doi.org/10.18565/therapy.2019.1.141-146

Mamedguseinova S.S., Kokorin V.A., Gordeev I.G.

Pirogov Russian National Research Medical University, Moscow
The article deals with the various aspects of treatment of patients with arterial hypertension in view of the updated ESC/ESH Guidelines (2018) and the possibilities of additional device-based methods of treatment, such as renal denervation, stimulation of carotid baroreceptors, denervation of the carotid body, stimulation of the median nerve and iliac arteriovenous anastomosis. Special attention was paid to the non-invasive methods of blood pressure correction, in particular, percutaneous electroneurostimulation.
Keywords: percutaneous electroneurostimulation, device-based treatment, antihypertensive therapy, arterial hypertension, blood pressure
Read entire article

Literature


  1. Ионов М.В., Звартау Н.Э., Конради А.О. Совместные клинические рекомендации ESH/ESC 2018 по диагностике и ведению пациентов с артериальной гипертензией: первый взгляд. Артериальная гипертензия. 2018; 24(3): 351–358.

  2. Fishman W.H., Henderson L.S., Lukas M.A. Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction. Vascular Health and Risk Management. 2008; 6: 1387–400.

  3. Бойцов С.А., Баланова Ю.А., Шальнова С.А. и др. Артериальная гипертония среди лиц 25–64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014; 4(14): 4–14.

  4. Lim S.S., Vos T., Flaxman A.D., Danaei G., Shibuya K. et al. Сomparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–60.

  5. ESH-ESC Guidelines Committee. 2018 ESH-ESC guidelines for the management of arterial hypertension. B. Williams, G. Mancia et al., J Hypertens 2018 and Eur Heart J. 2018, in press.

  6. DiBona G.F. Physiology in perspective: the wisdom of the body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol. 2005; 289: R633–41.

  7. 7Mahfoud F., Bohm M., Azizi M., Pathak A., Durand Zaleski I. et al. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. Eur Heart J. 2015; 36: 2219–27.

  8. Bohm M., Mahfoud F., Ukena C., Hoppe U.C., Narkiewicz K. et al. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension. 2015; 65: 766–74.

  9. Krum H., Schlaich M.P., Sobotka P.A., Bohm M., Mahfoud F. et al. Percutaneous renal denervation in patients with treatment resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet. 2014; 383: 622–29.

  10. 1Townsend R.R., Mahfoud F., Kandzari D.E., Kario K., Pocock S. et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTNOFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017; 390: 2160–70.

  11. Bhatt D.L., Kandzari D.E., O’Neill W.W., D’Agostino R., Flack J.M. et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393–401.

  12. Mathiassen O.N., Vase H., Bech J.N., Christensen K.L., Buus N.H. et al. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial. J Hypertens. 2016; 34: 1639–47.

  13. 1De Leeuw P.W., Bisognano J.D., Bakris G.L., Nadim M.K., Haller H. et al. Sustained reduction of blood pressure with baroreceptor activation therapy: results of the 6-year open follow-up. Hypertension. 2017; 69(5): 836–43.

  14. Spiering W., Williams B., van der Heyden J., van Kleef M., Lo R. et al. Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study. Lancet. 2017; 390: 2655–61.

  15. Burchell A.E., Lobo M.D., Sulke N., Sobotka P.A., Paton J.F. Arteriovenous anastomosis: is this the way to control hypertension? Hypertension. 2014;64:6–12.

  16. Ng F.L., Saxena M., Mahfoud F., Pathak A., Lobo M.D. Device-based therapy for hypertension. Curr Hypertens Rep. 2016; 18: 61.

  17. Lobo M.D., Sobotka P.A., Stanton A., Cockcroft J.R., Sulke N. et al. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial. Lancet. 2015; 385: 1634–41.

  18. Lobo M.D., Ott C., Sobotka P.A., Saxena M., Stanton A. et al. Central iliac arteriovenous anastomosis for uncontrolled hypertension: one-year results from the ROX CONTROL HTN trial. Hypertension. 2017; 70(6): 1099–105.

  19. 1McBryde F.D., Abdala A.P., Hendy E.B., Pijacka W., Marvar P. et al. The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension. Nat Commun. 2013; 4: 2395.

  20. Режим доступа: http://valenciatechnologies.com/hypertension

  21. Zhang C.L. Clinical investigation of acupuncture therapy. Clin J Med. 1956; 42: 514–17.

  22. Tam K.C., Yiu H.H. The effect of acupuncture on essential hypertension. Am J Chin Med. 1975; 3(4): 369–75.

  23. Flachskampf F.A., Gallasch J., Gefeller O. et al. Randomized trial of acupuncture to lower blood pressure. Circulation. 2007; 115(24): 3121–29.

  24. Terenteva N., Chernykh O., Sanchez-Gonzalez M.A., Wong A. Acupuncture therapy improves vascular hemodynamics and stiffness in middle-age hypertensive individuals. Complementary Therapies in Clinical Practice. 2018; 30: 14–18.

  25. Yang J., Chen J., Yang M., Yu S., Ying L. et al. Acupuncture for hypertension. Cochrane Database Syst Rev. 2018 Nov 14; 11: CD008821.

  26. Kalish L.A., Buczynski B., Connell P. et al. Stop Hypertension with the Acupuncture Research Program (SHARP): clinical trial design and screening results. Control Clin Trials. 2004; 25(1): 76–103.

  27. Sugioka K., Mao W., Woods J., Mueller R.A. An unsuccessful attempt to treat hypertension with acupuncture. Am J Chin Med. 1977; 5(1): 39–44.

  28. Dan N. Clinical observation on the effect of acupuncture on hypertension by ambulatory blood pressure monitor. Chin J Comb Trad Chin Med West Med. 1998; 18: 26–27.

  29. Li P., Tjen-A-Looi S.C., Guo Z.L., Fu L.-W., Longhurst J.C. Longloop pathways in cardiovascular electroacupuncture responses. J Appl Physiol. 2009; 106(2): 620–30.

  30. Li P., Tjen-A-Looi S.C., Cheng L., Liu D., Painovich J. et al. Long-lasting reduction of blood pressure by electroacupuncture in patients with hypertension: randomized controlled trial. Medical Acupuncture. 2015; 27(4): 253–66.

  31. Zhang J., Ng D., Sau A. Effects of electrical stimulation of acupuncture points on blood pressure. Journal of Chiropractic Medicine. 2009; 8(1): 9–14.

  32. Kimura K., Ishida K., Takahashi N., Toge Y., Tajima F. Effects of acupuncture at the ST-36 point on muscle sympathetic nerve activity and blood pressure in normal adults. Auton Neurosci. 2017; 208: 131–36.

  33. Vilela-Martin J.F., Giollo-Junior L.T., Chiappa G.R., Cipriano-Junior G., Vieira P.J.C. et al. Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial. Trials. 2016; 17: 168.

  34. Silverdal J., Mourtzinis G., Stener-Victorin E., Mannheimer C., Manhem K. Antihypertensive effect of low-frequency transcutaneous electrical nerve stimulation (TENS) in comparison with drug treatment. Blood Pressure. 2012; 21(5): 306–10.

  35. Свинцова Г.А. Возможности динамической электронейростимуляции для улучшения контроля резистентной артериальной гипертонии. Автореф. … дис. канд. мед. наук. Москва, 2010. 17 с.

  36. Физическая и реабилитационная медицина: национальное руководство / под ред. Г.Н. Пономаренко. М.: ГЭОТАР-Медиа, 2016. 688 с.

  37. Малахов В.В., Федоров А.А., Гуляев В.Ю., Рыжкин В.М., Ожгихин И.В. и др. Применение электростимулятора чрескожного «АВР-051» для коррекции артериального давления в клинической практике: методические рекомендации – Екатеринбург: УГМУ, 2018. 26 с.

  38. Пономаренко Г.Н. Применение электростимулятора «АВР-051» для коррекции артериального давления в клинической практике: методические рекомендации – Санкт-Петербург: ПСПбГМУ им. И.П. Павлова, 2018. – 16 с.


About the Autors

Sevinch S. Mamadguseinova, MD, assistant professor of the hospital therapy №1 Department of Pirogov Russian National research medical University of the Ministry of Healthcare of Russia. Address: 117997, Moscow, 1, Ostrovityanova str. Е-mail: audilovett@mail.ru
Valentin A. Kokorin, MD, PhD, associate professor of the hospital therapy №1 Department of Pirogov Russian National research medical University of the Ministry of Healthcare of Russia. Address: 117997, Moscow, 1, Ostrovityanova str. Е-mail: valentinkokorin@yahoo.com
Ivan G.Gordeev, Doctor of medicine, professor, head of the hospital therapy №1 Department of Pirogov Russian National research medical University of the Ministry of Healthcare of Russia. Address: 117997, Moscow, 1, Ostrovityanova str. E-mail: cardio-15@yandex.ru


Similar Articles

Back to Content

Бионика Медиа